MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease

    E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan (La Jolla, CA, USA)

    Objective: To investigate whether daytime sleepiness in newly diagnosed Parkinson’s disease (PD) patients predicts future dependency. Background: Excessive daytime sleepiness (EDS) is one of the…
  • 2019 International Congress

    Effect of a Combined Treatment with Botulinum Toxin and Biofeedback Exercises in Pisa Syndrome

    A. Castagna, A. Crippa, D. Anastasi, M. Meloni, A. Montesano, A. Marzegan (Milano, Italy)

    Objective: To assess the efficacy of a combined botulinum neurotoxin (BoNT) treatment with biofeedback exercises in a single Parkinson Disease (PD) patient with Pisa Syndrome…
  • 2019 International Congress

    Attentional Intervention to Improve Cognition and Gait in Parkinson’s Disease: Side of Onset Effects

    A. Cronin-Golomb, O. Barthelemy, A. Marin, B. Davis, S. Alshuaib, T. Ellis, J. Degutis (Boston, MA, USA)

    Objective: To establish whether home-based computerized attentional training would improve cognition, gait, and function in Parkinson’s disease (PD). Background: Impairments in cognition and gait are…
  • 2019 International Congress

    Levodopa response in later stages of Parkinson’s disease: a case-control study

    M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: To compare the response of motor and non-motor symptoms (NMS) to a L-dopa challenge test  between late stage (LS) PD patients and advanced stage…
  • 2019 International Congress

    Effect of Levodopa on gut microbiome in Parkinson’s Disease (PD)

    A. Hannoun, D. Ward, J. Flahive, J. Friedman, A. Deb, K. Smith (Worcester, MA, USA)

    Objective: To characterize changes in the gut microbiome in de novo PD subjects before and after initiating carbidopa/levodopa Background: The gastrointestinal microbiome in patients with…
  • 2019 International Congress

    Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment

    R. Jesus, R. Raimundo, C. Azoia, M. Mendes, V. Espirito-Santo, A. Almeida, I. Rego, AG. Velon (Vila Real, Portugal)

    Objective: Determine and compare lower body predominance and balance between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD)patients in a hospital-based sample. Background: Despite the recognition…
  • 2019 International Congress

    Is the personal Kinetigraph useful in the management of Parkinson´s disease patients? A retrospective study from a tertiary movement disorder center

    E. Krause, J. Randhawa, R. Mehanna (Houston, TX, USA)

    Objective: To assess the usefulness of the Personal KinetiGraph (PKG) in characterizing the intensity and timing of motor symptoms in Parkinson´s Disease (PD) patients. Background:…
  • 2019 International Congress

    Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease

    T. Lokhandwala, A. Lee, B. Yue, A. Thach, B. Navia (Palm Harbor, FL, USA)

    Objective: To describe correlations of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III scores with the 39-item Parkinson’s disease (PD) questionnaire…
  • 2019 International Congress

    The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, E. Gracheva, A. Istomina, M. Kotyleva, E. Agapova, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To investigate whether clinical phenotypes can be predicted by the assessment of gut microbiome and serum inflammatory profile of PD patients. Background: Recent evidence…
  • 2019 International Congress

    PARKINSON DISEASE HAMPERS PARTICIPATION IN THE CIVIC RESPONSIBILITY OF VOTING: a study of barriers to expression of a fundamental human right

    O. Oguntunde, O. Ojo, O. Agabi, M. Rizig, N. Okubadejo (Lagos, Nigeria)

    Objective: To determine the impact of PD on the participation of persons with Parkinson disease in the recently concluded national elections in Lagos,Nigeria, and explore…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • #24475 (not found)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley